The value of the UroVysion® FISH assay in the risk-stratification of patients with “atypical urothelial cells” in urinary cytology specimens-Reference-Cited by-同舟云学术

The value of the UroVysion® FISH assay in the risk-stratification of patients with “atypical urothelial cells” in urinary cytology specimens

Published:2017-04-11 Issue:6 Volume:45 Page:481-500
ISSN:8755-1039
Container-title:Diagnostic Cytopathology
language:en
Short-container-title:Diagn. Cytopathol.

Author:

Virk Renu K.¹,Abro Schuharazad¹,de Ubago Julianne Muus Martinez²,Pambuccian Stefan E.¹^ORCID,Quek Marcus L.³,Wojcik Eva M.¹,Mehrotra Swati¹,Chatt Grazina U.¹,Barkan Güliz A.¹

Affiliation:

1. Department of Pathology; Loyola University Medical Center; Maywood IL 60153

2. Department of Pathology; Northwestern University; Chicago IL

3. Department of Urology; Loyola University Medical Center; Maywood IL 60153

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Reference78 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Can we still afford bladder cancer?;Stenzl;Curr Opin Urol,2008

3. The role of urinary cytology for detection of bladder cancer;Planz;Eur J Surg Oncol,2005

4. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses;Lotan;Urology,2003

5. The Paris System for Reporting Urinary Cytology: the quest to develop a standardized terminology;Barkan;Acta Cytol,2016

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomorphological characteristics of low‐grade papillary urothelial carcinoma in voided urine samples: Distinction from benign and high‐grade papillary urothelial carcinoma;Cytopathology;2024-07-11

2. Molecular Markers for Bladder Cancer Screening: An Insight into Bladder Cancer and FDA-Approved Biomarkers;International Journal of Molecular Sciences;2023-09-21

3. Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis;Cancers;2023-01-24

4. Liquid biopsy in bladder cancer: State of the art and future perspectives;Critical Reviews in Oncology/Hematology;2022-02

5. The Paris System for Reporting Urinary Cytology: A Meta-Analysis;Journal of Personalized Medicine;2022-01-27